Year-end Sale % OFF 
Abstract
We would like to respond to the comments made by Pu Song and Xingshun Xu about the chosen administration of IV immunoglobulin (IVIG), which is based on a regimen for chronic inflammatory demyelinating polyneuropathy (CIPD). These authors also expressed doubts about our conclusion that IVIG was not effective in patients with painful with idiopathic small fiber neuropathy (I-SFN).
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
